Biopharmaceutical Innovator in Neurodegenerative Diseases
us
Origami Therapeutics, Inc. is a Biopharmaceutical Innovator in Neurodegenerative Diseases with 1.5K followers across 1 platform.
Last updated
Origami Therapeutics is a preclinical-stage biopharmaceutical company focused on developing novel protein degrader therapeutics for neurodegenerative diseases such as Huntington’s Disease, Alzheimer’s, Parkinson’s, ALS, and Frontotemporal Dementia. The company leverages a proprietary drug discovery platform to target and degrade disease-causing proteins, aiming to create transformative therapies. Origami Therapeutics is led by founder Beth Hoffman, a veteran drug discovery scientist known for her work on cystic fibrosis treatments. The company collaborates with leading drug development firms to advance its pipeline.
Pioneering the next-generation of small molecules targeting disease-causing proteins.
| Social Media | Score | Followers | Eng. rate | Growth | Last Activity |
|---|---|---|---|---|---|
| Origami Therapeutics, Inc.@origami-therapeutics | 46/100 | 1.5K | 0.82% | 0.0%+0 | 28 months ago |
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
